Stenocare A/S (CPH:STENO)
Denmark
· Delayed Price · Currency is DKK 0.452
-0.040 (-8.13%)
Feb 21, 2025, 4:26 PM CET
Stenocare Market Cap
Stenocare has a market cap or net worth of 9.03 million as of February 21, 2025. Its market cap has decreased by -79.76% in one year.
Market Cap
9.03M
Enterprise Value
12.73M
Revenue
2.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.45
Market Cap Chart
Since May 18, 2020, Stenocare's market cap has decreased from 326.86M to 9.03M, a decrease of -97.24%. That is a compound annual growth rate of -52.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 9.03M | -65.23% |
| Dec 30, 2024 | 25.97M | -43.63% |
| Dec 29, 2023 | 46.08M | -56.10% |
| Dec 30, 2022 | 104.96M | -11.04% |
| Dec 30, 2021 | 117.98M | -47.32% |
| Dec 30, 2020 | 223.96M | -31.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 2,642.57B |
| Coloplast | 179.01B |
| Genmab | 100.87B |
| Demant | 56.75B |
| Zealand Pharma | 53.27B |
| H. Lundbeck | 37.77B |
| Ambu A/S | 37.73B |
| ALK-Abelló | 34.28B |